Epidemiology of Hypertension in Chronic Kidney Disease During One Year in Ambulatory Service of Hypertension in Durrës
DOI:
https://doi.org/10.56345/ijrdv12n113Keywords:
Hypertension, chronic kidney disease, prevalence, risk factors, AlbaniaAbstract
Hypertension is a common and significant health problem worldwide, affecting approximately one billion individuals. Chronic kidney disease (CKD) is a progressive and irreversible condition, with hypertension being one of the most common comorbidities. The relationship between hypertension and CKD is complex and bidirectional, as hypertension is a major cause of CKD, and CKD can contribute to the development and worsening of hypertension. Additionally, hypertension is a major risk factor for cardiovascular disease, which is the leading cause of morbidity and mortality in patients with CKD. This abstract summarizes a study that aimed to investigate the prevalence of CKD in patients with essential hypertension in Albania and to identify associated risk factors. The study found a prevalence of 13.2% of CKD in patients with essential hypertension, which is comparable to other studies in the United States. Additionally, the study found that CKD was more prevalent in women and that diastolic blood pressure was significantly higher in patients with CKD. The study also evaluated the number and types of antihypertensive medications used to achieve target blood pressure levels, finding that the number of medications was significantly higher in patients with CKD and that ACE inhibitors or ARBs were the most commonly used medications. In conclusion, this study provides important information about the prevalence and risk factors associated with CKD in patients with essential hypertension in Albania. Early identification and management of hypertension and CKD are essential in reducing the burden of cardiovascular disease and improving patient outcomes.
Received: 5 January 2025 / Accepted: 7 March 2025 / Published: 25 March 2025
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.